Imagion Biosystems Limited (ASX:IBX) (the Company), a Company dedicated to improving healthcare through the earlier detection of cancer, is pleased to share the updated investor presentation.
Chief Executive Officer Robert (Bob) Proulx is conducting an investor roadshow in Sydney, Melbourne and Perth from Monday 9 – Friday 13 September, 2019.
Download the investor presentation.
Imagion Biosystems Delivers Major Milestone — IND Application Lodged with U.S. FDA for Phase 2 Trial of MagSense® HER2 Imaging Agent
January 31, 2026
Imagion Biosystems Hits Major Milestone, Submits IND Application to U.S. FDA for Phase 2 Trial of MagSense® HER2 Imaging Agent Key Highlights: Imagion Biosystems has